Many multiple sclerosis (MS) patients report that cannabis has beneficial effects on their symptoms with minimal side effects, according to a survey that also showed that varying effects on health may be due to differences in how users consume cannabis.
Findings from the survey were reported in the study, “Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal,” published in the journal Multiple Sclerosis and Related Disorders.
Increasing evidence suggests that cannabis and cannabinoid-based medicines may have therapeutic effects on different diseases, including MS, triggering increased public interest in its medicinal use.
Previous studies have, in fact, shown symptom relief in MS patients using cannabinoid-based medicines, namely reduced pain and muscle spasticity. It is estimated that 16 percent of MS patients use cannabis for medicinal purposes.
The medicinal properties of the plant can be attributed to cannabinoids, which are chemical compounds in cannabis. Cannabinoids can bind to cannabinoid receptors in human cells, affecting their cellular behavior.
Although cannabis contains more than 100 cannabinoids, two of them, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), are the most well-known. While the psychoactive THC molecule stimulates certain receptors of the central nervous system, the non-psychoactive CBD molecule suppresses these receptors as well as other receptors found on immune cells.
As a result of its therapeutic benefits, cannabinoid-based medicines are becoming increasingly available, which has also resulted in more variability in cannabis consumption practices, namely concerning types of cannabinoids or ingestion methods.
To better understand these characteristics, researchers investigated cannabis use among MS patients and its perceived effect on MS-related symptoms.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?